Your Shopping Cart
 |
 |
Historic Perspectives on Clinical Use and Efficacy of Silver (part 6)
|
by Eric J. Rentz, DO, MSc Bechhold, H, Colloids in Biology and Medicine, NY, D. van Nostrand, 1919; p. 364-76. Thompson, NR, Comprehensive Inorganic Chemistry, Pergamon Press, Elmsford, NY, 1973; Vol. 5, Chapter 28. Hippocrates, “On Ulcers,” 400 B.C.E.; translated by Francis Adams, © 1994-2000: http://classics.mit.edu/Browse/browse-Hippocrates.html Blakeney, EH, [ed] The History of Herodotus, translated by Rawlinson, G; London. Cumston, CG, History of Medicine, A.A. Knoff Co., NY, 1926; p. 216. Charcot and Ball, Dictionaire Encyclopedique des Sciences Medicals, P. Asselin, Sr. de Labes, V. Masson & Sons, 1867; 6:68-74. Gettler, AO, Rhoads, CP, Weiss, S, “A Contribution to the Pathology of Generalized Argyria with a Discussion on the Fate of Silver in the Human Body,” Am J Pathol, 1927; 3:63151. Hill, WR, Pillsbury, MA, Argyria: The Pharmacology of Silver, The Williams & Wilkins Company, Baltimore, 1939; p. 2. Raulin, J, Sci Nature 11 (1869):93, Berk (3) Abstract 1. Berk, RG, “Abstracts of articles on oligodynamic sterilization.” The Engineer Board, US Army Corps of Engineers [Project WS 768], Fort Belvoir, Virginia. Von Nageli, KW, Denschr Schweiz Naturforsch Ges 33 (1893):174, Berk (3) Abstract 5. Crede, KSF, Ber Klin Wochenschr, 1901; 38:941. Zhao, G, Stevens, SE, “Multiple Parameters for the Comprehensive Evaluation of the Susceptibility of Escherichia coli to the Silver Ion,” BioMetals, 1998; 11:27. Sykes, G, “Disinfection and Sterilization” 2 nd Ed, (1965) Spon, London. Tobler, T, Schweiz Med Wchnschr, 1922; 52:774. Hill, WR, Pillsbury, DM, Argyria: The Pharmacology of Silver, The Williams & Wilkins Co., Baltimore, 1939; p. 169. Voigt, J, Ztschr f d ges exper Med, 1926; 52:33-40. Hall, RE, Bender, G, Marquis, RE, “Inhibitory and Cidal Antimicrobial Actions of Electrically Generated Silver Ions,” J Oral Maxillofac Surg, 1987; 45:783. McHugh, GL, et al., “Salmonella typhymurium Resistant to Silver Nitrate, Chloramphenicol and Ampicillin,” Lancet, 1975; 1:235. Summers, AO, et al., “Metal Cation and Osyanion Resistances in Plasmids of Gram Negative Bacteria,” In: Schlessinger, edit. Microbiology, Am Soc Microbiol, Washington, DC, 1978. Bridges, K, et al., “Gentamicin and Silver Resistant Pseudomonas in a Burn Unit,” Br Med J, 1979; 1:446. Hamilton-Miller, JM, Shah, S, Smith, C, “Silver Sulfadiazine: A Comprehensive in vitro Reassessment,” Chemotherapy, 1993; 39:405-9. Grier, N, “Silver and Its Compounds,” In: Disinfection, Sterilization and Preservation, S. Block, edit. Lea & Febiger, Philadelphia, PA, 1983, p. 385 Fox, CL, “Silver Sulfadiazine – A New Topical Agent,” Arch Surg, 1968; 96:184-8. Becker, RO, Spadaro, JA, “Treatment of Orthopaedic Infections with Electrically Generated Silver Ions,” J Bone Jt Surg, 1978; 60:871-81. Etris, S, “Clinical Experiments Show Silver Compound Can Help AIDS Patients: Researchers Say Silver Oxide Offsets AIDS Loss of Immune Response,” In: The Silver Institute’s Silver News – February-March 1998; www.silverinstitute.org Kim, TN, et al., “Antimicrobial Effects of Metal Ions (Ag +, Cu 2+, Zn 2+) in Hydroxyapatite,” J Mater Sci Mater Med, 1998; 9:129-34. Berger, TJ, et al., “Electrically Generated Silver Ions: Quantitative Effects on Bacterial and Mammalian Cells,” Anti Microb Agents, 1976; 9(2): 357-8. Zhao, G, Stevens, SE, “Multiple Parameters for the Comprehensive Evaluation of the Susceptibility of Escherichia coli to the Silver Ion,” BioMetals, 1998; 11:28. Hill, WR, Pillsbury, DM, Argyria: The Pharmacology of Silver, The Williams & Wilkins Co., Baltimore, 1939; p. 169. Duhamel, BG, “Electro Metallic Colloids, Etc.,” The Lancet, January 13 th, 1912. Simpson, WJ, Hewlett, RT, “Experiments on the Germicidal Action of Colloidal Silver,” The Lancet, December 12 th, 1914; p. 359. Sanderson-Wells, TH, “A Case of Puerperal Septicemia Successfully Treated with Intravenous Injections of Collosol Argentum,” The Lancet, February 16 th, 1916; p. 258. Fuller, AW, “Epidemic Encephalitis of Severe Type,” The Lancet, July 24 th, 1926; 2:172. “Colloidal Solutions and Artificial Enzymes,” Brit Med J, February 3 rd, 1912; 6:252-4. Marshall , CR, Killoh, GB, “The Bactericidal Action of Collosols of Silver and Mercury,” Brit Med J, January 16 th, 1915; 1:102-3. Roe, AL, “Collosol Argentum and its Ophthalmic Uses,” Brit Med J, January 16 th, 1915; 3:104. Morris, M, “The Therapeutic Effects of Colloidal Preparations,” Brit Med J, May 12 th, 1917; 1:617. Pilcher, JD, Sollmann, T, “Organic, Protein and Colloidal Silver Compounds: Their Antiseptic Efficiency and Silver-Ion Content as a Basis for Their Classification,” The Journal of Laboratory and Clinical Medicine, 1923; p. 301-10. Cliver, DO, et al., “Biocidal Effects of Silver: Contract NAS 9-9300 Final Technical Report,” University of Wisconsin, February 1970; p. 5. In vitro investigations published on letterheads from Departments of Microbiology, Pathology, Infectious Diseases, Immunology, and Biology. Etc… from such universities as: Johns Hopkins, Northwestern Univ. Medical School, Queen’s University, University of Arkansas for Medical Sciences, Georgetown University Medical Center, NYU Medical Center, University of Nebraska, University of Massachusetts, etc…circa 1996-1998. K et al., “Sonographically Guided Percutaneous Treatment of Hepatic Hydatid Cysts: Long-Term Results,” J Clin Ultrasound, Nov-Dec 2000; 28(9): 469-78. Etris, S, “Clinical Experiments Show Silver Compound Can help AIDS Patients: Researchers Say Silver Oxide Offsets AIDS Loss of Immune Response,” In: The Silver Institute’s Silver News – February-March 1998; www.silverinstitute.org Dean, W, et al., “Reduction of Viral Load in AIDS Patients with Intravenous Mild Silver Protein – Three Case Reports,” Clinical Practice of Alternative Medicine, Spring, 2001. Tokumaru, T, Shimizu, CL For, “Antiviral Activities of Silver Sulfadiazine in Ocular Infections, “ Res Com Chem Pathol Pharmacol, 1974; 8(1): 151. Chang, TW, L Weinstein, “In vitro Activity of Silver Sulfadiazine Against Herpesvirus hominis,” J Infect Dis, Jul 1975; 132(1): 79-81. Becker, RO, Spadaro JA, “Treatment of Orthopedic Infections with Electrically Generated Silver Ions,” J Bone Jt Surg, 1978; 60-A: 871. Chu, CC, et al., “Newly Made Antibacterial Braided Nylon Sutures. 1. In vitro Qualitative and in vivo Preliminary Biocompatibility Study,” J Biomed Mater Res, 1987; 21:1281. Dietch, EA, et al., “Silver-Nylon Cloth: In vitro and in vivo Evaluation of Antimicrobial Activity,” J Trauma, 1987; 27:301 Haeger, K, “Preoperative Treatment of Leg Ulcers with Silver Spray and Aluminum Foil,” Acta Chir Scand, 1963; 125:32. Marchant, RE, Miller, KM, Anderson, JM, “In vivo Leukocyte Interactions with Biomer,” J Biomed Mater Res, 1984; 18:1169. Modak, SM, Sampath, L, Fox, CL, “Combined Use of Silver Sulfadiazine and Antibiotics as a Possible Solution to Bacterial Resistance in Burn Wounds,” J Burn Care, July/August, 1988; 9(4): 359. Spadaro, JA, Becker, RO, “Some Specific Cellular Effects of Electrically Injected Silver and Gold Ions,” Bioelectrechem Bioenergetics, 1976; 3:49. Webster, DA, et al., “Silver Anode Treatment of Chronic Osteomyelitis,” Clin Orthop, 1981; 1961:105. Shvets, I, DeLaurentis, M, Beard, RB, Pourreyzaei, K, Trans 20 th Annual Meeting – Society for Biomaterials, Boston (1994). DeLaurentis, M, Shvets, I, Beard, RB, Pourreyzaei, K, Trans 20 th Annual Meeting – Society for Biomaterials, Boston (1994). Beard, RB, DeLaurentis, M, Pourrezaei, K, Adrian, S, “Stimulation, Recording Potential and Antimicrobial Medical Catheter Coatings,” Metal-Based Drugs Vol 1, 5-6 (1994):445-458, Freund Pub House Ltd, London. < Prev Goto Contents |
